IL10 and melanoma: Others have found that the synthetic IL-10 analogue peptide, IT9302, can interact with IL-10 receptor and mimic its anti-inflammatory effects both in vitro in human melanoma cells [37] (in monocyte differentiation to TGF-β dendritic cells [26]) and in rabbits subjected to acute pancreatitis [38] and acute lung injury [39].